According to a controversial point of view, Reelin–receptor interaction is a critical neuroprotective mechanism, and impairment of this interaction might contribute directly to the pathophysiological cascade of AD, culminating in Aβ and tau toxic effects [1]. The gene discussed is MAPT; the disease is Alzheimer disease.